Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Suzanne M Shema. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Suzanne M Shema zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ONXX / Onyx Pharmaceuticals Inc | EVP,GC and Corp. Secretary | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Suzanne M Shema. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Suzanne M Shema ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -16 700 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -24 563 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -903 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -16 510 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -2 157 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -12 489 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -3 553 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -3 281 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -1 969 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -1 214 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options |
D - Sale to Issuer | -12 472 | 0 | -100,00 | ||||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | -28 150 | 0 | -100,00 | 125,00 | -3 518 750 | ||
| 2013-10-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
U - Other | -6 468 | 28 150 | -18,68 | 125,00 | -808 500 | 3 518 750 | |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 16 042 | -4,76 | ||||
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 25 466 | -3,03 | ||||
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -583 | 18 667 | -3,03 | ||||
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 5 250 | -11,11 | ||||
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 215 | 13 686 | -8,15 | ||||
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 052 | 34 618 | -10,48 | 131,86 | -534 297 | 4 564 729 |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 38 670 | 2,12 | 35,18 | 28 214 | 1 360 411 | |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 868 | 2,15 | 37,68 | 29 993 | 1 426 866 | |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 072 | 1,60 | 37,68 | 21 967 | 1 396 873 | |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 489 | 1,83 | 30,28 | 19 864 | 1 104 887 | |
| 2013-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 35 833 | 3,51 | 32,07 | 38 965 | 1 149 164 | |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 26 262 | -2,94 | ||||
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -583 | 19 250 | -2,94 | ||||
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 16 844 | -4,54 | ||||
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -657 | 5 906 | -10,01 | ||||
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 214 | 14 901 | -7,53 | ||||
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 052 | 34 618 | -10,48 | 135,76 | -550 100 | 4 699 740 |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 38 670 | 2,10 | 37,68 | 29 993 | 1 457 086 | |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 874 | 1,56 | 37,68 | 21 967 | 1 427 092 | |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 291 | 2,20 | 35,18 | 28 214 | 1 311 897 | |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 36 489 | 1,83 | 30,28 | 19 894 | 1 104 887 | |
| 2013-07-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 832 | 3,51 | 32,07 | 38 933 | 1 149 132 | |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 27 058 | -2,86 | ||||
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -584 | 19 833 | -2,86 | ||||
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | -802 | 17 646 | -4,35 | ||||
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 6 563 | -9,09 | ||||
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 214 | 16 115 | -7,01 | ||||
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 100 | 34 618 | -3,08 | 92,06 | -101 268 | 3 186 999 |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 952 | 35 718 | -7,63 | 90,91 | -268 376 | 3 247 241 |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 38 670 | 2,10 | 37,68 | 29 993 | 1 457 086 | |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 584 | 37 874 | 1,57 | 37,68 | 22 005 | 1 427 092 | |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 290 | 2,20 | 35,18 | 28 214 | 1 311 862 | |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 488 | 1,83 | 30,28 | 19 864 | 1 104 857 | |
| 2013-06-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 832 | 3,51 | 32,07 | 38 933 | 1 149 132 | |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -795 | 27 854 | -2,77 | ||||
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -583 | 20 417 | -2,78 | ||||
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 18 448 | -4,17 | ||||
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 215 | 17 329 | -6,55 | ||||
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 7 219 | -8,33 | ||||
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 378 | 34 618 | -3,83 | 90,01 | -124 034 | 3 115 966 |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -802 | 35 996 | -2,18 | 89,99 | -72 172 | 3 239 280 |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 871 | 36 798 | -4,84 | 89,94 | -168 278 | 3 309 612 |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 795 | 38 669 | 2,10 | 37,68 | 29 956 | 1 457 048 | |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 874 | 1,56 | 37,68 | 21 967 | 1 427 092 | |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 37 291 | 2,20 | 35,18 | 28 214 | 1 311 897 | |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 36 489 | 3,44 | 32,07 | 38 965 | 1 170 202 | |
| 2013-05-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 274 | 1,89 | 30,28 | 19 864 | 1 068 097 | |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -803 | 19 250 | -4,00 | ||||
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 28 649 | -2,70 | ||||
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -583 | 21 000 | -2,70 | ||||
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 214 | 18 544 | -6,14 | ||||
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 7 875 | -7,69 | ||||
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -803 | 34 618 | -2,27 | 89,16 | -71 596 | 3 086 551 |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 803 | 35 421 | 2,32 | 35,18 | 28 250 | 1 246 111 | |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 379 | 34 618 | -3,83 | 89,16 | -122 952 | 3 086 558 |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 35 997 | 2,26 | 37,68 | 29 993 | 1 356 367 | |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 35 201 | 1,68 | 37,68 | 21 967 | 1 326 374 | |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 870 | 34 618 | -5,12 | 89,19 | -166 790 | 3 087 673 |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 36 488 | 3,44 | 32,07 | 38 933 | 1 170 170 | |
| 2013-04-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 274 | 1,89 | 30,28 | 19 864 | 1 068 097 | |
| 2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 335 | 34 618 | -6,32 | 86,14 | -201 137 | 2 981 995 |
| 2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -808 | 36 953 | -2,14 | 86,14 | -69 601 | 3 183 131 |
| 2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 500 | 37 761 | -3,82 | 91,78 | -137 670 | 3 465 705 |
| 2013-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -572 | 39 261 | -1,44 | 89,60 | -51 251 | 3 517 786 |
| 2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 16 700 | 16 700 | |||||
| 2013-04-01 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 6 000 | 39 833 | 17,73 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 29 445 | -2,63 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -584 | 21 583 | -2,63 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 20 053 | -3,85 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -657 | 8 531 | -7,15 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 215 | 19 758 | -5,79 | ||||
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 054 | 33 833 | -10,70 | 79,72 | -323 185 | 2 697 167 |
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 887 | 2,15 | 37,68 | 29 993 | 1 427 582 | |
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 584 | 37 091 | 1,60 | 37,68 | 22 005 | 1 397 589 | |
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 507 | 2,25 | 35,18 | 28 214 | 1 284 316 | |
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 35 705 | 1,87 | 30,28 | 19 894 | 1 081 147 | |
| 2013-03-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 215 | 35 048 | 3,59 | 32,07 | 38 965 | 1 123 989 | |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -796 | 30 241 | -2,56 | ||||
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -583 | 22 167 | -2,56 | ||||
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 20 855 | -3,70 | ||||
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 9 188 | -6,66 | ||||
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 214 | 20 973 | -5,47 | ||||
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 051 | 33 833 | -10,69 | 77,52 | -314 034 | 2 622 734 |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 796 | 37 884 | 2,15 | 37,68 | 29 993 | 1 427 469 | |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 583 | 37 088 | 1,60 | 37,68 | 21 967 | 1 397 476 | |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 505 | 2,25 | 35,18 | 28 214 | 1 284 246 | |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 703 | 1,87 | 30,28 | 19 864 | 1 081 087 | |
| 2013-02-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 214 | 35 047 | 3,59 | 32,07 | 38 933 | 1 123 957 | |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -2 388 | 31 037 | -7,14 | ||||
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 050 | 22 750 | -4,41 | ||||
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -802 | 21 657 | -3,57 | ||||
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 9 844 | -6,25 | ||||
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 344 | 22 187 | -5,71 | ||||
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 500 | 33 833 | -4,25 | 81,99 | -122 985 | 2 773 968 |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 740 | 35 333 | -11,83 | 81,12 | -384 509 | 2 866 213 |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 388 | 40 073 | 6,34 | 37,68 | 89 980 | 1 509 951 | |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 050 | 37 685 | 2,87 | 37,68 | 39 564 | 1 419 971 | |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 802 | 36 635 | 2,24 | 35,18 | 28 214 | 1 288 819 | |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 35 833 | 1,86 | 30,28 | 19 864 | 1 085 023 | |
| 2013-01-09 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 35 177 | 3,97 | 32,07 | 43 102 | 1 128 126 | |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -4 775 | 33 425 | -12,50 | ||||
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -2 100 | 23 800 | -8,11 | ||||
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 208 | 22 459 | -12,50 | ||||
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 10 500 | -5,88 | ||||
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 345 | 23 531 | -5,41 | ||||
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -14 398 | 33 833 | -29,85 | 77,68 | -1 118 437 | 2 628 147 |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 775 | 48 231 | 10,99 | 37,68 | 179 922 | 1 817 344 | |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 100 | 43 456 | 5,08 | 37,68 | 79 128 | 1 637 422 | |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 208 | 41 356 | 8,41 | 35,18 | 112 857 | 1 454 904 | |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 38 148 | 1,75 | 30,28 | 19 864 | 1 155 121 | |
| 2012-12-12 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 345 | 37 492 | 3,72 | 32,07 | 43 134 | 1 202 368 | |
| 2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 344 | 24 876 | -5,13 | ||||
| 2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -657 | 11 156 | -5,56 | ||||
| 2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 001 | 36 147 | -5,25 | 75,14 | -150 355 | 2 716 086 |
| 2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 38 148 | 3,65 | 32,07 | 43 102 | 1 223 406 | |
| 2012-11-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 657 | 36 804 | 1,82 | 30,28 | 19 894 | 1 114 425 | |
| 2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 344 | 26 220 | -4,88 | ||||
| 2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 11 813 | -5,26 | ||||
| 2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 36 147 | -5,24 | 91,01 | -182 020 | 3 289 738 |
| 2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 38 147 | 3,65 | 32,07 | 43 102 | 1 223 374 | |
| 2012-10-10 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 36 803 | 1,81 | 30,28 | 19 864 | 1 114 395 | |
| 2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 345 | 27 564 | -4,65 | ||||
| 2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -656 | 12 469 | -5,00 | ||||
| 2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 001 | 42 397 | -4,51 | 77,88 | -155 838 | 3 301 878 |
| 2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 345 | 44 398 | 3,12 | 32,07 | 43 134 | 1 423 844 | |
| 2012-09-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 43 053 | 1,55 | 30,28 | 19 864 | 1 303 645 | |
| 2012-09-06 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 721 | 42 397 | -3,90 | 72,78 | -125 254 | 3 085 654 |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | -12 833 | 25 667 | -33,33 | ||||
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | -2 100 | 25 900 | -7,50 | ||||
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | -1 344 | 28 909 | -4,44 | ||||
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Options (Right to Buy) |
M - Exercise | -656 | 13 125 | -4,76 | ||||
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -14 933 | 44 118 | -25,29 | 71,97 | -1 074 728 | 3 175 172 |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 59 051 | -3,28 | 71,79 | -143 580 | 4 239 271 |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 833 | 61 051 | 26,61 | 35,18 | 451 465 | 2 147 774 | |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 100 | 48 218 | 4,55 | 37,68 | 79 128 | 1 816 854 | |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 344 | 46 118 | 3,00 | 32,07 | 43 102 | 1 479 004 | |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 656 | 44 774 | 1,49 | 30,28 | 19 864 | 1 355 757 | |
| 2012-08-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 550 | 44 118 | -12,93 | 71,93 | -471 146 | 3 173 439 | |
| 2012-07-27 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 971 | 50 668 | -5,54 | 73,97 | -219 770 | 3 747 993 |
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 719 | 13 781 | -35,90 | ||||
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -16 747 | 30 526 | -35,43 | ||||
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 265 | 53 639 | -7,37 | 68,53 | -292 280 | 3 675 881 |
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -20 201 | 57 904 | -25,86 | 67,49 | -1 363 365 | 3 907 941 |
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 719 | 78 105 | 10,97 | 30,28 | 233 731 | 2 365 019 | |
| 2012-07-11 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 747 | 70 386 | 31,22 | 32,07 | 537 076 | 2 257 279 | |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -10 000 | 21 500 | -31,75 | ||||
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -30 000 | 47 000 | -38,96 | ||||
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 53 639 | -15,71 | 44,44 | -444 351 | 2 383 454 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 63 639 | -13,58 | 44,48 | -444 750 | 2 830 345 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 73 639 | -11,96 | 44,61 | -446 146 | 3 285 375 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 000 | 83 639 | -4,56 | 44,58 | -178 334 | 3 728 911 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 000 | 87 639 | -3,31 | 44,60 | -133 800 | 3 908 699 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 000 | 90 639 | -3,20 | 44,57 | -133 710 | 4 039 780 |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 93 639 | 11,96 | 30,28 | 302 800 | 2 835 389 | |
| 2012-06-08 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
M - Exercise | 30 000 | 83 639 | 55,93 | 32,07 | 962 100 | 2 682 303 | |
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | -694 | 53 639 | -1,28 | 36,58 | -25 385 | 1 962 013 |
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | -568 | 54 333 | -1,03 | 36,58 | -20 776 | 1 987 376 |
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 28 000 | 28 000 | |||||
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 38 200 | 38 200 | |||||
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 17 150 | 54 901 | 45,43 | ||||
| 2012-04-03 |
|
4 | ONXX |
ONYX PHARMACEUTICALS INC
Common Stock |
A - Award | 7 500 | 37 751 | 24,79 |